We also leverage the medical expertise we hold across geographies and therapeutic areas; a holistic R&D strategy that drives both new and complex-product development as well as expanding access to generics; and strong academic, policy, commercial and notfor-profit partnerships that allow us to scale access to new and existing products while also encouraging disease awareness and advancing healthcare infrastructure.